17/12/2025
🚨 BIG news in MS research 🚨
A new oral medication called “fenebrutinib” just showed unprecedented results in Phase 3 clinical trials…
…and it could be a *major* breakthrough for both relapsing and primary progressive MS (PPMS). 🤯
Here’s what you need to know:
💥 It’s the first BTK inhibitor to show positive results in both relapsing + progressive MS.
💥 In relapsing MS, it reduced relapse rates more effectively than Aubagio.
💥 In PPMS, it worked as well as Ocrevus at slowing disability progression, with signs of benefit as early as 6 months.
💥 It’s an oral medication (not an infusion), which could make treatment easier and more accessible.
If you’re living with MS (especially progressive MS), this research offers real hope for the future.
It’s still under review, but these results mark one of the biggest steps forward we’ve seen in years, which I’m incredibly excited about as an MS Specialist. 👩⚕️
👇 Comment “ARTICLE” and I’ll send you a link to the full story!